TW254945B - - Google Patents

Info

Publication number
TW254945B
TW254945B TW082100078A TW82100078A TW254945B TW 254945 B TW254945 B TW 254945B TW 082100078 A TW082100078 A TW 082100078A TW 82100078 A TW82100078 A TW 82100078A TW 254945 B TW254945 B TW 254945B
Authority
TW
Taiwan
Prior art keywords
pct
sec
formula
date
pub
Prior art date
Application number
TW082100078A
Other languages
English (en)
Chinese (zh)
Original Assignee
Upsa Experiment Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upsa Experiment Co Ltd filed Critical Upsa Experiment Co Ltd
Application granted granted Critical
Publication of TW254945B publication Critical patent/TW254945B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
TW082100078A 1992-01-08 1993-01-07 TW254945B (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9200138A FR2685918B1 (fr) 1992-01-08 1992-01-08 Nouveaux derives de l'adenosine, leurs procedes de preparation, compositions pharmaceutiques les contenant.

Publications (1)

Publication Number Publication Date
TW254945B true TW254945B (enExample) 1995-08-21

Family

ID=9425478

Family Applications (1)

Application Number Title Priority Date Filing Date
TW082100078A TW254945B (enExample) 1992-01-08 1993-01-07

Country Status (25)

Country Link
US (2) US5229505A (enExample)
EP (1) EP0623138B1 (enExample)
JP (1) JP3224542B2 (enExample)
KR (1) KR100232672B1 (enExample)
AT (1) ATE153342T1 (enExample)
AU (1) AU661894B2 (enExample)
CA (1) CA2127472C (enExample)
CZ (1) CZ289047B6 (enExample)
DE (1) DE69219901T2 (enExample)
DK (1) DK0623138T3 (enExample)
EE (1) EE03087B1 (enExample)
ES (1) ES2105285T3 (enExample)
FI (1) FI106205B (enExample)
FR (1) FR2685918B1 (enExample)
GE (1) GEP19981357B (enExample)
GR (1) GR3024386T3 (enExample)
HU (1) HU221304B1 (enExample)
LV (1) LV11899B (enExample)
MD (1) MD502G2 (enExample)
NZ (1) NZ246904A (enExample)
RU (1) RU2129560C1 (enExample)
SK (1) SK282205B6 (enExample)
TW (1) TW254945B (enExample)
UA (1) UA44221C2 (enExample)
WO (1) WO1993014102A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2685918B1 (fr) * 1992-01-08 1995-06-23 Union Pharma Scient Appl Nouveaux derives de l'adenosine, leurs procedes de preparation, compositions pharmaceutiques les contenant.
FR2714907B1 (fr) * 1994-01-07 1996-03-29 Union Pharma Scient Appl Nouveaux dérivés de l'Adénosine, leurs procédés de préparation, compositions pharmaceutiques les contenant.
WO1995018817A1 (fr) * 1994-01-07 1995-07-13 Laboratoires Upsa Nouveaux derives de l'adenosine, leurs procedes de preparation, compositions pharmaceutiques les contenant
TW528755B (en) 1996-12-24 2003-04-21 Glaxo Group Ltd 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
FR2772271B1 (fr) * 1997-12-11 2000-09-01 Union Pharma Scient Appl Nouvelle association pharmaceutique a activite analgesique
YU44900A (sh) 1998-01-31 2003-01-31 Glaxo Group Limited Derivati 2-(purin-9-il)tetrahidrofuran-3,4-diola
US6495528B1 (en) 1998-06-23 2002-12-17 Smithkline Beecham Corporation 2-(Purin -9-yl)-tetrahydrofuran-3,4-diol derivatives
JP2002173427A (ja) * 1998-09-01 2002-06-21 Yamasa Shoyu Co Ltd 眼疾患治療用医薬組成物
DE19924818A1 (de) 1999-05-29 2000-11-30 Bayer Ag Substituierte Phenylcyclohexancarbonsäureamide
EP1229901B1 (en) * 1999-11-17 2009-03-18 Boston Scientific Limited Microfabricated devices for the delivery of molecules into a carrier fluid
AU2001278708A1 (en) * 2000-09-08 2002-03-22 Toa Eiyo Ltd. Adenosine derivatives and use thereof
EP1352910A1 (en) * 2002-04-10 2003-10-15 Grünenthal GmbH New analogs of nitrobenzylthioinosine
PE20060272A1 (es) 2004-05-24 2006-05-22 Glaxo Group Ltd (2r,3r,4s,5r,2'r,3'r,4's,5's)-2,2'-{trans-1,4-ciclohexanodiilbis-[imino(2-{[2-(1-metil-1h-imidazol-4-il)etil]amino}-9h-purin-6,9-diil)]}bis[5-(2-etil-2h-tetrazol-5-il)tetrahidro-3,4-furanodiol] como agonista a2a
GB0514809D0 (en) 2005-07-19 2005-08-24 Glaxo Group Ltd Compounds
US12261115B2 (en) 2021-01-27 2025-03-25 Taiwan Semiconductor Manufacturing Company, Ltd. Semiconductor devices and methods of manufacturing thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE788958A (fr) * 1971-09-18 1973-03-19 Schering Ag Derives d'adenosine et leur procede de preparation
US4167565A (en) * 1976-11-08 1979-09-11 Abbott Laboratories Adenosine-5'-carboxamides and method of use
US5310731A (en) * 1984-06-28 1994-05-10 Whitby Research, Inc. N-6 substituted-5'-(N-substitutedcarboxamido)adenosines as cardiac vasodilators and antihypertensive agents
US4755594A (en) * 1986-01-31 1988-07-05 Warner-Lambert Company N6 -substituted adenosines
JPH0696534B2 (ja) * 1986-04-25 1994-11-30 ヘキストジヤパン株式会社 抗痴呆剤
AU8276187A (en) * 1986-10-31 1988-05-25 Warner-Lambert Company Selected n6-substituted adenosines having selective a2 binding activity
WO1988003148A2 (en) * 1986-10-31 1988-05-05 Warner-Lambert Company Heteroaromatic derivatives of adenoside
IL84414A0 (en) * 1986-11-14 1988-04-29 Ciba Geigy Ag N9-cyclopentyl-substituted adenine derivatives
SU1661367A1 (ru) * 1988-11-01 1991-07-07 Всесоюзный научно-исследовательский институт по креплению скважин и буровым растворам Способ гидрофобизации тампонажных материалов
ES2095960T3 (es) * 1990-09-25 1997-03-01 Rhone Poulenc Rorer Int Compuestos que tienen propiedades antihipertensivas y antiisquemicas.
FR2685918B1 (fr) * 1992-01-08 1995-06-23 Union Pharma Scient Appl Nouveaux derives de l'adenosine, leurs procedes de preparation, compositions pharmaceutiques les contenant.

Also Published As

Publication number Publication date
MD502F1 (en) 1996-03-29
SK81894A3 (en) 1995-04-12
HU9402040D0 (en) 1994-09-28
KR100232672B1 (ko) 1999-12-01
JP3224542B2 (ja) 2001-10-29
ATE153342T1 (de) 1997-06-15
GR3024386T3 (en) 1997-11-28
AU3455093A (en) 1993-08-03
EP0623138A1 (fr) 1994-11-09
DK0623138T3 (da) 1997-12-15
EE03087B1 (et) 1998-04-15
DE69219901D1 (de) 1997-06-26
CZ289047B6 (cs) 2001-10-17
UA44221C2 (uk) 2002-02-15
GEP19981357B (en) 1998-08-25
EP0623138B1 (fr) 1997-05-21
RU94039545A (ru) 1997-04-27
JPH07502738A (ja) 1995-03-23
ES2105285T3 (es) 1997-10-16
LV11899A (lv) 1997-12-20
FR2685918A1 (fr) 1993-07-09
AU661894B2 (en) 1995-08-10
MD502G2 (ro) 1996-11-30
FI943222A0 (fi) 1994-07-06
US5229505A (en) 1993-07-20
FI106205B (fi) 2000-12-15
US5480983A (en) 1996-01-02
SK282205B6 (sk) 2001-12-03
FI943222L (fi) 1994-08-18
HUT68095A (en) 1995-05-29
NZ246904A (en) 1995-04-27
CA2127472C (en) 2003-11-18
DE69219901T2 (de) 1997-11-13
CA2127472A1 (en) 1993-07-22
WO1993014102A1 (fr) 1993-07-22
FR2685918B1 (fr) 1995-06-23
CZ164394A3 (en) 1995-02-15
HU221304B1 (en) 2002-09-28
RU2129560C1 (ru) 1999-04-27
LV11899B (lv) 1998-03-20

Similar Documents

Publication Publication Date Title
GR3035414T3 (en) Novel imidazole derivatives, their preparation and therapeutic applications.
PL310171A1 (en) Novel imidazopyridines
NO952321D0 (no) Polypeptid, samt anti-HIV-preparat fremstilt fra dette
GR3035621T3 (en) New pyrimidone derivatives with antifungal activity
LV11899A (lv) Jauni adenozina atvasinajumi to iegusanas panemiens
FI954579A0 (fi) Uusia pednisolonijohdannaisia
AU2776092A (en) Dermatological and/or cosmetological composition containing retinoids
GB9418912D0 (en) Pharmaceutically active compounds
AU666422B2 (en) Novel bicyclic pyrimidine compounds, method for preparing same and pharmaceutical compositions containing said compounds
SE9402880D0 (sv) New peptide derivatives
ZA949593B (en) N-substituted azabicycloheptane derivatives their preparation and use
CS9100438A2 (en) New derivative of beta-phenylisoserine, method of its preparation and its application
IL104816A0 (en) Indoles
IL108288A0 (en) Pyrrolidine derivatives, their preparation and medicaments containing them
ZA938414B (en) Substituted ortho-ethenylphenylacetic acid derivatives
IL104049A0 (en) 7'-amino-naphthazarin antibiotic derivatives
SE9401596D0 (sv) New compounds

Legal Events

Date Code Title Description
MK4A Expiration of patent term of an invention patent